- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.19: 2 residues within 4Å:- Chain A: F.59, N.61
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.120, N.123, V.125
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: Q.113, E.130, N.163
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.232
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.280
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.601
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: Y.653, N.655
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.707
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain A: A.704, E.1070, N.1072
- Ligands: NAG.29
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Ligands: NAG.28
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: F.59, N.61
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.120, N.123, V.125
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: Q.113, E.130, N.163
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain A: K.460, E.463, R.464
- Chain B: N.232
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.280
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.601
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: Y.653, N.655
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.707
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain B: A.704, E.1070, N.1072
- Ligands: NAG.40
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Ligands: NAG.39
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: F.59, N.61
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.120, N.123, V.125
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: Q.113, E.130, N.163
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.232
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.280
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.601
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.614, T.616, Q.642
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: Y.653, N.655
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain C: N.707
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain C: A.704, E.1070, N.1072
- Ligands: NAG.51
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Ligands: NAG.50
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chi, X. et al., Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants. Cell Discov (2023)
- Release Date
- 2023-07-12
- Peptides
- Spike glycoprotein: ABC
heavy chain of XGv289: DFH
light chain of XGv289: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IH
JE
LG
MI
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chi, X. et al., Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants. Cell Discov (2023)
- Release Date
- 2023-07-12
- Peptides
- Spike glycoprotein: ABC
heavy chain of XGv289: DFH
light chain of XGv289: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IH
JE
LG
MI
N